Core Viewpoint - Goldman Sachs initiated coverage of Healthpeak Properties Inc. with a Neutral rating and a price target of $17, highlighting improving occupancy and cash flow visibility in senior housing investments [1] Group 1: Company Overview - Healthpeak Properties Inc. operates as a fully integrated healthcare REIT, focusing on acquiring, developing, owning, leasing, and managing healthcare real estate across the United States [4] Group 2: Recent Developments - Healthpeak's portfolio has significantly changed since 2019, particularly due to the merger with Physicians Realty Trust, which closed on March 1, 2024, effectively doubling the size of its outpatient medical portfolio [2] - On January 7, Healthpeak announced plans to form and take public Janus Living, Inc., a new REIT focused entirely on senior housing, contributing its 34-community, 10,422-unit senior housing portfolio to Janus Living [3]

Core Insights - Healthpeak Properties, Inc. reported fourth-quarter 2025 funds from operations (FFO) as adjusted per share of 47 cents, exceeding the Zacks Consensus Estimate of 45 cents and slightly up from 46 cents in the prior-year quarter [1][8] - The company generated revenues of $719.4 million, surpassing the Zacks Consensus Estimate of $699.5 million, reflecting a year-over-year increase of 3.1% [2] - Full-year FFO, as adjusted, was $1.84 per share, above the Zacks Consensus Estimate of $1.83, and improved 1.7% year over year [2] Financial Performance - Healthpeak reported a 3.9% year-over-year growth in total merger-combined same-store cash (adjusted) net operating income (NOI) [4] - The outpatient medical and continuing care retirement community (CCRC) segments experienced year-over-year growth of 4.1% and 16.7%, respectively, while the lab segment saw a decline of 0.3% [4] - Interest expenses increased by 14.4% year over year to $80.6 million [5] Strategic Initiatives - The company announced the formation of Janus Living, Inc., a senior housing REIT, and plans for an initial public offering (IPO) [3] - Healthpeak is restructuring its portfolio by selling stabilized assets and reinvesting the proceeds into value-accretive investments [3] - The company is focusing on technology innovation initiatives to enhance automation, decision-making speed, and client service [3] Balance Sheet - Healthpeak ended the fourth quarter with cash and cash equivalents of $467.5 million, a significant increase from $91 million as of September 30, 2025 [6] - The net debt to adjusted EBITDAre ratio was 5.2X as of December 31, 2025 [6] 2026 Outlook - The company expects FFO as adjusted per share to be between $1.70 and $1.74, while the Zacks Consensus Estimate is currently at $1.84 [7] - Total merger-combined same-store cash (adjusted) NOI growth is projected to range from negative 1% to 1% [7]

Core Viewpoint - The REIT and Equity Trust - Other industry is positioned to benefit from strong demand in specialized sectors such as industrial, data centers, healthcare, and modern office properties, driven by e-commerce growth, AI workloads, and aging populations [1][4]. Industry Overview - The Zacks REIT and Equity Trust - Other sector includes a variety of REIT stocks across asset categories like industrial, office, healthcare, and data centers, with economic growth being a key driver for real estate demand and occupancy rates [3]. - The performance of Equity REITs is influenced by the dynamics of their underlying assets and geographic locations, necessitating a thorough analysis before investment decisions [3]. Future Trends - Demand for specialized real estate is enhancing growth visibility, with industrial properties benefiting from e-commerce, data centers from cloud adoption and AI, and healthcare real estate from aging populations [4]. - Office markets are stabilizing as companies invest in modern, amenity-rich workplaces to improve employee engagement [4]. Financial Positioning - REITs are well-positioned to leverage a favorable interest rate environment, which supports property valuations and long-term capital planning [5]. - Prudent financial strategies, including fixed-rate debt and access to various capital sources, enhance operational flexibility and competitive advantage [5]. Risks - Asset obsolescence is a significant risk, with older properties struggling to compete against modern, technology-enabled spaces favored by tenants [2][6]. Industry Performance - The REIT and Equity Trust - Other industry has underperformed compared to the S&P 500 and the broader Finance sector, with a growth of 5.9% versus 21.8% and 19.4% respectively over the past year [11]. - The industry currently trades at a forward 12-month price-to-FFO ratio of 15.32, below the S&P 500's P/E of 23.45 and the Finance sector's P/E of 17.35 [13]. Stock Recommendations - **Postal Realty Trust (PSTL)**: Focuses on properties leased to the USPS, with a high occupancy rate of 99.8% and a disciplined growth strategy, acquiring 216 properties for $123 million at a 7.7% cash cap rate [17][18]. - **Industrial Logistics Properties Trust (ILPT)**: Owns 411 properties with a strong occupancy rate of around 94%, benefiting from positive leasing economics and a diverse tenant base [21][22]. - **Prologis (PLD)**: The largest industrial REIT, with a portfolio that supports high occupancy levels and strong rent growth, currently holding around $7.5 billion in liquidity [25][27].

Core Viewpoint - National Healthcare Properties, Inc. (NHP) is set to release its financial results for the third quarter of 2025 on November 5, 2025, after market close [1]. Group 1: Financial Results Announcement - NHP will announce its third quarter financial results for the period ending September 30, 2025, on November 5, 2025 [1]. - The announcement will be followed by a webcast hosted by NHP's executive leadership on November 6, 2025, at 1:00 p.m. ET to review the results [2]. Group 2: Company Overview - National Healthcare Properties, Inc. is a publicly registered real estate investment trust (REIT) that focuses on acquiring a diversified portfolio of healthcare real estate, particularly in seniors housing and outpatient medical facilities across the United States [3].

Core Insights - Healthpeak Properties, Inc. reported third-quarter 2025 adjusted funds from operations (FFO) per share of 46 cents, surpassing the Zacks Consensus Estimate of 45 cents and matching the prior year's figure [1][8] - The company generated revenues of $705.9 million, exceeding the Zacks Consensus Estimate of $696 million, with a slight year-over-year increase [2][8] - Total merger-combined same-store cash (adjusted) net operating income (NOI) grew by 0.9% year-over-year, with outpatient medical and CCRC segments showing growth of 2.0% and 9.4%, respectively, while the lab segment declined by 3.2% [3][8] Financial Performance - Healthpeak executed new and renewal leases totaling 339,000 square feet in the lab portfolio, achieving positive cash-releasing spreads of 4.6% on renewals, while the outpatient medical portfolio saw 1.2 million square feet with 5.4% cash-releasing spreads [4] - Interest expenses increased by 3.6% year-over-year to $76.8 million [4][8] - The company exited the quarter with cash and cash equivalents of $91 million, up from $89.4 million as of June 30, 2025, and had a net debt to adjusted EBITDAre ratio of 5.3X [5] 2025 Outlook - Healthpeak reaffirmed its guidance for 2025, expecting adjusted FFO per share to be between $1.81 and $1.87, with the Zacks Consensus Estimate at $1.83 [6] - The company anticipates total merger-combined same-store cash (adjusted) NOI growth in the range of 3-4% [6]

Core Insights - Healthpeak Properties, Inc. (DOC) is a Denver-based real estate investment trust (REIT) focused on healthcare real estate, with a market cap of $12.8 billion, specializing in life science, outpatient medical, and senior housing [1] - The company has experienced a 20.5% decline from its 52-week high of $23.26, while shares have increased by 8.2% over the past three months, underperforming the Nasdaq Composite's 17.2% rise [2] - Over the past 52 weeks, DOC shares have fallen 16%, compared to a 27% increase in the Nasdaq Composite, and are down 8.7% year-to-date, while the Nasdaq has risen by 18% [3] Financial Performance - In Q2, DOC reported revenue of $694.3 million, a slight year-over-year decline, which missed consensus expectations, leading to a 6.7% drop in shares following the announcement [4] - AFFO per share increased by 2.2% to $0.46, aligning with analyst forecasts, and total merger-combined same-store cash adjusted NOI rose by 3.5% compared to the previous year [4] Competitive Position - DOC's underperformance is notable when compared to Omega Healthcare Investors, Inc. (OHI), which has seen a 1.6% increase over the past 52 weeks and an 8.5% rise year-to-date [5]